Our Department

Department Alumni Fest 2016

People Directory

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.

User menu

Publications by Gabriela V. Cohen Freue

2015

Tremlett H, Dai DLY, Hollander Z, Kapanen A, Aziz T, Wilson-McManus JE, et al. Serum proteomics in multiple sclerosis disease progression. Journal of proteomics. Elsevier; 2015; 118: 2–11*Senior Author.

2014

Hollander Z, Lazárová M, Lam KKY, Ignaszewski A, Oudit GY, Dyck JRB, et al.. Proteomic biomarkers of recovered heart function. European journal of heart failure. Wiley Online Library; 2014; 16: 551–559.

2013

Freue GVCohen, Ortiz-Molina H, Zamar RH. A natural robustification of the ordinary instrumental variables estimator. Biometrics. Wiley Online Library; 2013; 69: 641–650.
Lin D*, Freue GCohen*, Hollander Z, Mancini GBJohn, Sasaki M, Mui A, et al. Plasma protein biosignatures for detection of cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation. Elsevier; 2013; 32: 723–733.*Equal contributors.
Freue GVCohen, Meredith A, Smith D, Bergman A, Sasaki M, Lam KKY, et al. Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation. PLoS Comput Biol. Public Library of Science; 2013; 9: e1002963.
Hollander Z, Chen V, Sidhu K, Lin D, Ng RT, Balshaw R, et al. Predicting acute cardiac rejection from donor heart and pre-transplant recipient blood gene expression. JOURNAL OF HEART AND LUNG TRANSPLANTATION. 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA: ELSEVIER SCIENCE INC; 2013; 32: 259-265. DOI: 10.1016/j.healun.2012.11.008

2012

Günther OP, Chen V, Freue GCohen, Balshaw RF, Tebbutt SJ, Hollander Z, et al.. A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers. BMC bioinformatics. BioMed Central; 2012; 13: 1.
Singh A, Freue GVCohen, Oosthuizen JL, Kam SHY, Ruan J, Takhar MK, et al. Plasma proteomics can discriminate isolated early from dual responses in asthmatic individuals undergoing an allergen inhalation challenge. PROTEOMICS-Clinical Applications. 2012; 6: 476–485.
Domanski D*, Freue GVCohen*, Sojo L, Kuzyk MA, Ratkay L, Parker CE, et al. The use of multiplexed MRM for the discovery of biomarkers to differentiate iron-deficiency anemia from anemia of inflammation. Journal of proteomics. Elsevier; 2012; 75: 3514–3528.*Equal contributors.
Freue GVCohen, Borchers CH. Multiple Reaction Monitoring (MRM) Principles and Application to Coronary Artery Disease. Circulation: Cardiovascular Genetics. Am Heart Assoc; 2012; 5: 378–378.
Domanski D, Percy AJ, Yang J, Chambers AG, Hill JS, Freue GVCohen, et al. MRM-based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma. Proteomics. Wiley Online Library; 2012; 12: 1222–1243.

2011

Mayrand-Chung S, Cohen-Freue G, Hollander Z. Models for Collaborations and Computational Biology. Collaborative Computational Technologies for Biomedical Research. John Wiley & Sons, Inc.; 2011;: 39–53.
Ohlund LB, Hardie DB, Elliott MH, Camenzind AG, Smith DS, Reid JD, et al. Standard operating procedures and protocols for the preparation and analysis of plasma samples using the iTRAQ methodology. In Sample Preparation in Biological Mass Spectrometry. Springer Netherlands; 2011. pp. 575–624.
Lin D, Hollander Z, Meredith A, Stadnick E, Sasaki M, Freue GCohen, et al. Molecular signatures of end-stage heart failure. Journal of cardiac failure. Churchill Livingstone; 2011; 17: 867–874.
Domanski D, Smith DS, Miller CA, Yang Y, Jackson AM, Freue GCohen, et al. High-flow multiplexed MRM-based analysis of proteins in human plasma without depletion or enrichment. Clinics in laboratory medicine. Elsevier; 2011; 31: 371–384.
Heydari B, Leipsic J, Mancini GB, Min JK, Labounty T, Taylor C, et al. Diagnostic performance of high-definition coronary computed tomography angiography performed with multiple radiation dose reduction strategies. Can J Cardiol. 2011; 27: 606–612.

2010

Freue GVCohen, Sasaki M, Meredith A, Günther OP, Bergman A, Takhar M, et al.. Proteomic signatures in plasma during early acute renal allograft rejection. Molecular & Cellular Proteomics. American Society for Biochemistry and Molecular Biology; 2010; 9: 1954–1967.
Hollander Z, Lin D, Chen V, Ng R, Wilson-McManus J, Ignaszewski A, et al. Whole blood biomarkers of acute cardiac allograft rejection: double-crossing the biopsy. Transplantation. LWW; 2010; 90: 1388–1393.

2009

Lin D, Hollander Z, Ng RT, Imai C, Ignaszewski A, Balshaw R, et al. Whole blood genomic biomarkers of acute cardiac allograft rejection. The Journal of Heart and Lung Transplantation. Elsevier; 2009; 28: 927–935.
Günther OP, Balshaw RF, Scherer A, Hollander Z, Mui A, Triche TJ, et al.. Functional genomic analysis of peripheral blood during early acute renal allograft rejection. Transplantation. LWW; 2009; 88: 942–951.

2007

Freue GVCohen, Hollander Z, Shen E, Zamar RH, Balshaw R, Scherer A, et al. MDQC: a new quality assessment method for microarrays based on quality control reports. Bioinformatics. 2007; 23: 3162–3169.
Cohen-Freue G, Holzer TR, Forney JD, W. McMaster R. Global gene expression in Leishmania. INTERNATIONAL JOURNAL FOR PARASITOLOGY. THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND: PERGAMON-ELSEVIER SCIENCE LTD; 2007; 37: 1077-1086. DOI: 10.1016/j.ijpara.2007.04.011
Freue GVCohen. The Pitman estimator of the Cauchy location parameter. Journal of statistical planning and inference. North-Holland; 2007; 137: 1900–1913.
Leifso K, Cohen-Freue G, Dogra N, Murray A, W. McMaster R. Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: The Leishmania genome is constitutively expressed. MOLECULAR AND BIOCHEMICAL PARASITOLOGY. PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS: ELSEVIER SCIENCE BV; 2007; 152: 35-46. DOI: 10.1016/j.molbiopara.2006.11.009